Literature DB >> 20085694

An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland.

C N Ramsay1, A Stirling, J Smith, G Hawkins, T Brooks, J Hood, G Penrice, L M Browning, S Ahmed.   

Abstract

An investigation is currently underway to explore and control an outbreak of Bacillus anthracis among drug users (mainly injecting) in Scotland. Contaminated heroin or a contaminated cutting agent mixed with the heroin is considered to be the most likely source and vehicle of infection. Heroin users have been advised of the risk. The risk to the general public is regarded as very low.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20085694     DOI： 10.2807/ese.15.02.19465-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  27 in total

1.  A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation.

Authors:  Vivian D Hope; Norah Palmateer; Lucas Wiessing; Andrea Marongiu; Joanne White; Fortune Ncube; David Goldberg
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

Review 2.  Armies of pestilence: CNS infections as potential weapons of mass destruction.

Authors:  B L Hart; L Ketai
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-04       Impact factor: 3.825

Review 3.  Defense at the border: the blood-brain barrier versus bacterial foreigners.

Authors:  Nina M van Sorge; Kelly S Doran
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

4.  Mouse monoclonal antibodies to anthrax edema factor protect against infection.

Authors:  Clinton E Leysath; Kuang-Hua Chen; Mahtab Moayeri; Devorah Crown; Rasem Fattah; Zhaochun Chen; Suman R Das; Robert H Purcell; Stephen H Leppla
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

5.  Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions.

Authors:  Daniel Ciccarone; George Jay Unick; Jenny K Cohen; Sarah G Mars; Daniel Rosenblum
Journal:  Drug Alcohol Depend       Date:  2016-04-14       Impact factor: 4.492

6.  Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in canines.

Authors:  Amisha V Barochia; Xizhong Cui; Junfeng Sun; Yan Li; Steven B Solomon; Thi-Sau Migone; G Mani Subramanian; Sally D Bolmer; Peter Q Eichacker
Journal:  J Infect Dis       Date:  2012-01-05       Impact factor: 5.226

Review 7.  An overview of anthrax infection including the recently identified form of disease in injection drug users.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2012-04-24       Impact factor: 17.440

8.  Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.

Authors:  Laith Altaweel; Zhaochun Chen; Mahtab Moayeri; Xizhong Cui; Yan Li; Junwu Su; Yvonne Fitz; Syd Johnson; Stephen H Leppla; Robert Purcell; Peter Q Eichacker
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

Review 9.  New insights into gastrointestinal anthrax infection.

Authors:  Jennifer L Owen; Tao Yang; Mansour Mohamadzadeh
Journal:  Trends Mol Med       Date:  2014-12-19       Impact factor: 11.951

Review 10.  Updating perspectives on the initiation of Bacillus anthracis growth and dissemination through its host.

Authors:  Zachary P Weiner; Ian J Glomski
Journal:  Infect Immun       Date:  2012-02-21       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.